Understanding who does what in a clinical trial isn’t just a formality. It shapes how studies are structured, how responsibilities are assigned, and how regulatory accountability flows from start to finish.
What Is a Clinical Trial Sponsor?
According to International Council for Harmonisation Good Clinical Practice (ICH GCP) guidelines, a sponsor is an individual, company, institution, or organization that takes responsibility for initiating, managing, and financing a clinical trial.
Sponsors are typically pharmaceutical or biopharmaceutical companies, medical device manufacturers, academic institutions, or government agencies. Before clinical research can begin, the Food and Drug Administration (FDA) requires sponsors to submit an Investigational New Drug (IND) application, which includes animal study data, manufacturing details, and clinical protocols. Sponsors planning for a multi-site trial with global reach, or for trials outside of the U.S., should comply with the regulations of local entities such as the European Medicines Agency (EMA),
Critically, the sponsor holds ultimate regulatory accountability, regardless of how many tasks are delegated to external partners.
Core sponsor responsibilities include:
- Designing the trial protocol.
- Submitting regulatory applications, such as INDs.
- Ensuring participant safety through submitting to an IRB.
- Reporting serious adverse events to regulatory authorities.
- Overseeing all contracted partners.
What Is a CRO in Clinical Research?
A contract research organization (CRO) is a company contracted by a sponsor to perform one or more trial-related functions. CROs exist to extend a sponsor’s operational capacity, providing specialized expertise that sponsors may not have in-house or may need to scale quickly.
CRO services span the full clinical development lifecycle, from Phase I through Phase IV studies, and can include:
- Protocol development and regulatory strategy
- Site identification and activation
- Clinical monitoring and data management
- Biostatistics and medical writing
- Safety reporting support
When a sponsor delegates tasks to a CRO, they assume responsibility for those specific functions. However, the sponsor cannot transfer its ultimate regulatory accountability. That distinction is central to how both parties structure their working relationship.
How Do Sponsors and CROs Work Together?
The sponsor-CRO relationship is a structured partnership built on clearly defined contracts and oversight frameworks. Sponsors select CROs based on therapeutic expertise, geographic reach, operational capacity, and prior performance.
Once engaged, the CRO operates as an extension of the sponsor’s team. Communication, reporting cadences, and escalation paths are all agreed upon upfront. The sponsor continues to monitor performance and remains the primary point of contact with regulatory agencies.
Some sponsors outsource only specific functions, such as data management or site monitoring, to a specialized CRO. Others delegate most operational functions to a full-service CRO while retaining strategic oversight internally. The right model depends on the sponsor’s internal capabilities, trial complexity, and therapeutic area.
Where Does WCG Fit In?
WCG serves as a trusted partner to both sponsors and CROs, providing expertise, data, and technology-enabled solutions across all phases of clinical research. WCG is involved in 94 percent of all FDA-approved therapeutic agents over the past five years and partners with the top eight CROs globally, as well as more than 200 small to mid-sized CROs.
Whether a sponsor needs a qualified site network, IRB services, recruitment support, or protocol consulting, WCG delivers solutions that reduce complexity and protect study timelines. In today’s clinical research landscape, operational efficiency isn’t optional. It’s foundational.
Frequently Asked Questions
CRO stands for contract research organization. A CRO is a company that provides outsourced research services to sponsors, including pharmaceutical, biotech, and medical device companies, to support the planning and execution of clinical trials.
A CRO can take on sponsor responsibilities if formally designated to do so by the original sponsor, but this arrangement must be explicitly documented and accepted by the CRO in writing, per ICH GCP guidelines.
The sponsor holds ultimate regulatory accountability for a clinical trial. A CRO assumes responsibility only for the specific tasks delegated to it under contract. If a CRO fails to meet its obligations, the sponsor may still be held accountable by regulatory authorities.
No. Smaller academic or government-funded trials may be conducted entirely by the sponsor’s internal team. Larger, complex studies, particularly those spanning multiple countries and sites, more commonly engage CROs to manage operational scale.
Sponsors should evaluate a CRO’s therapeutic area expertise, regulatory track record, site network, data management capabilities, and experience with the specific trial phase. Cultural fit and communication practices also play an important role in long-term collaboration.
Plan your study and overcome challenges with confidence.
Whether you have questions regarding regulatory compliance, site identification, or study reviews, WCG’s experts are ready to provide answers and help prepare your study for what’s next. Complete the form to get in touch today.